Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00945061 · ClinicalTrials.gov registry record · NA

Radiation Therapy in Treating Patients With Recurrent Breast Cancer

A NA study, sponsored by Case Comprehensive Cancer Center.

Completed
Registry status
NA
Development phase
13
Enrollment target

NCT00945061 is a NA study that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 13 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00945061, a NA study, has completed, sponsored by Case Comprehensive Cancer Center.

COMPLETED
Registry status
NA
Development phase
13 participants
Enrollment target

Study Summary

RATIONALE: Radiation therapy uses high-energy x-rays and other types of radiation to kill tumor cells. It is not yet known whether a single dose of radiation therapy is more effective than implant radiation therapy for 5 days in treating patients with recurrent breast cancer. PURPOSE: This phase II trial is studying implant radiation therapy to see how well it works compared with radiation therapy during surgery in treating patients with recurrent breast cancer.

Interventions

  • RADIATION intraoperative radiation therapy
  • RADIATION intracavitary balloon brachytherapy

Trial Details

FieldValue
Enrollment Target 13 participants
Start Date 2008-09-23
Est. Completion 2018-07-06
Phase NA

Sponsor

Case Comprehensive Cancer Center

407 total trials

What the Registry Record Tells You About NCT00945061

The ClinicalTrials.gov registry entry for NCT00945061 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which intraoperative radiation therapy is the first listed.

NCT00945061 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00945061 about?

NCT00945061 is a clinical study titled "Radiation Therapy in Treating Patients With Recurrent Breast Cancer". RATIONALE: Radiation therapy uses high-energy x-rays and other types of radiation to kill tumor cells. It is not yet known whether a single dose of radiation therapy is more effective than implant radiation therapy for 5 days in treating patients with recurrent breast cancer. PURPOSE: This phase II...

What is the current status of trial NCT00945061?

This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2008-09-23. Estimated completion is 2018-07-06.

What interventions are being tested in trial NCT00945061?

The interventions under investigation include: intraoperative radiation therapy (RADIATION), intracavitary balloon brachytherapy (RADIATION).

Who is sponsoring clinical trial NCT00945061?

This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.